Medication info

DaeHan 3% Sodium Chloride Solution

Prescription medicationIntravenous injection
Ingredient · strength
Sodium Chloride›30g / 1000mL
Manufacturer / importer
DaeHan Pharmaceutical Industry Co., Ltd.
Appearance
A colorless and transparent solution with a slight salty taste filled in a colorless and transparent glass or polypropylene, multilayer film plastic container.
Packaging
Bottle - 500 milliliters/bottle, Ampoule - 5 ampoules/box [5mL/ampoule]
Approval status
Active

MFDS item code 199800385 · Notified 1998.12.16 · Insurance code 645100191

Summary

Main use
Correction of electrolyte deficiencies (including hyponatremia) and extracellular fluid dilution
Who receives it
Adults
Adult administration
Administer the dose determined according to theoretical requirements slowly by intravenous infusion at a rate of no more than 100mL per hour as sodium chloride, and do not exceed 400mL over 24 hours. The dose and infusion rate should be adjusted appropriately according to age, body weight, and symptoms. Fluid and electrolyte balance should be monitored during administration.

Ingredients

Manufacturer
DaeHan Pharmaceutical Industry Co., Ltd.

Efficacy & effects

Correction of electrolyte deficiencies (including hyponatremia) and extracellular fluid dilution

  • Hyponatremia
  • hypochloremia
  • excessive fluid intake
  • extracellular fluid dilution
  • severe salt depletion.
View approved original text

This medication is used to quickly replenish electrolytes and fluids in the body. It is particularly effective in cases of electrolyte imbalances such as hyponatremia or hypochloremia. It is also used when excessive amounts of water have been ingested due to repeated enemas or when extracellular fluid has been rapidly diluted during transurethral prostatectomy. Additionally, it aids in emergency treatment during severe salt depletion. It is effective in improving electrolyte and fluid imbalances in various conditions.

How it is given

Adult administration

Administer the dose determined according to theoretical requirements slowly by intravenous infusion at a rate of no more than 100mL per hour as sodium chloride, and do not exceed 400mL over 24 hours. The dose and infusion rate should be adjusted appropriately according to age, body weight, and symptoms. Fluid and electrolyte balance should be monitored during administration.

Precautions

When using this medication for injection, be very careful when cutting the ampoule, as glass shards may mix in. Special caution should be taken when administering to children and the elderly. It is recommended not to administer this medication to patients with high, normal, or slightly low electrolyte levels in the plasma. Moreover, use should be avoided in situations where the administration of sodium and chloride may be harmful. Administration should be done with caution in patients with heart or circulatory problems, kidney diseases, low protein levels, cirrhosis, edema, conditions of excess blood volume or urinary obstruction, patients taking corticosteroids or corticotropin, salt retention patients, children, elderly individuals, and post-surgical patients. Rapid or excessive administration of this medication can lead to heart failure, edema, acidosis, and serum electrolyte abnormalities. Additionally, symptoms such as fever, tissue damage, pain or infection at the injection site, phlebitis, thrombosis, and blood volume overload may occur. Following surgery, symptoms such as cellular dehydration, weakness, confusion, appetite loss, nausea, abdominal distension, shortness of breath, decreased urine output, and elevation in blood test values may occur. If adverse reactions occur, immediately stop administration, assess the patient's condition, and provide appropriate treatment. During treatment, fluid and electrolyte balance and acid-base balance should be periodically monitored, and the patient's condition should be closely observed. It is advisable not to administer excessive electrolytes, minerals, or vitamins during this time. Safety has not been established for pregnant women; therefore, this medication should only be used when the benefits of treatment outweigh the risks. Additionally, it is unknown whether this medication is secreted in breast milk, so it should be administered to breastfeeding women with caution. In case of overdose, symptoms such as anxiety, weakness, thirst, dry mouth, tongue swelling, skin flushing, fever, dizziness, headache, nausea, abdominal distension, deep breathing, loss of appetite, local pain, fever, extravasation, blood volume overload, serum electrolyte abnormalities, acidosis, oliguria, elevated BUN, venous irritation, venous thrombosis, abscess, injection site infection, and injection site pain may appear. Elevated blood levels of sodium and chloride due to excessive dosing can lead to acidosis, so if symptoms appear, the patient's condition should be re-evaluated immediately and appropriate measures taken. When mixing this medication with other additives, carefully check the turbidity or precipitation of the mixture before and during administration, and avoid using plastic containers as connecting tubes. It is recommended to change intravenous infusion devices every 24 hours. Only use solutions that are transparent and in unblemished containers or packaging.

Side effects

  • Congestive heart failure
  • edema
  • acidosis
  • serum electrolyte abnormalities
  • fever
  • tissue necrosis
  • injection site infection
  • abscess
  • localized pain
  • venous irritation
Show 22 more
  • venous thrombosis
  • phlebitis
  • extravascular leakage
  • hypervolemia
  • cellular dehydration
  • weakness
  • disorientation
  • loss of appetite
  • nausea
  • abdominal bloating
  • deep breathing
  • oliguria
  • elevated BUN
  • restlessness
  • thirst
  • dry mouth
  • swollen tongue
  • skin flushing
  • hypotension
  • tachycardia
  • dizziness
  • headache

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air ingress, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

A colorless and transparent solution with a slight salty taste filled in a colorless and transparent glass or polypropylene, multilayer film plastic container.

Package unit

Bottle - 500 milliliters/bottle, Ampoule - 5 ampoules/box [5mL/ampoule]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.